Utility Patent Cases
Coverage since November 3, 1994

Utility Patent

Uncategorized

Sanofi-Synthelabo v. Apotex — Federal Circuit Upholds Plavix Patent, Holds Racemic Mixture Does Not Anticipate Isolated Enantiomer

The Federal Circuit affirmed the validity of Sanofi’s Plavix (clopidogrel) patent, holding that prior disclosure of a racemic mixture does not anticipate a claim to an isolated single enantiomer — particularly when the enantiomer exhibits unexpectedly superior properties not predictable from t

Uncategorized

Kyocera Wireless v. ITC — Federal Circuit Limits ITC Power to Exclude Downstream Products of Non-Parties in Section 337 Cases

The Federal Circuit held that the ITC’s limited exclusion order authority under Section 337 does not extend to downstream products of non-parties to the investigation — rejecting the ITC’s longstanding practice of excluding finished goods containing infringing components made by responde

Uncategorized

Finisar Corp. v. DirecTV Group — Federal Circuit Reverses $78.9M Verdict on Claim Construction and Means-Plus-Function Software Disclosure

The Federal Circuit vacated a $78.9 million willful infringement verdict against DirecTV’s satellite broadcasting system, reversing on claim construction and holding that means-plus-function claims for software functions require more than a bare reference to software — the specification must d

Uncategorized

Aristocrat Technologies v. International Game Technology — Federal Circuit Requires Algorithm Disclosure for Computer-Implemented Means-Plus-Function Claims

The Federal Circuit affirmed the invalidation of Aristocrat’s slot machine patent, holding that computer-implemented means-plus-function claims are indefinite under § 112 unless the specification discloses the specific algorithm that transforms a general-purpose computer into the claimed speci

Scroll to Top